We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Bioo Scientific Launches In-Vivo siRNA Delivery Reagent
Product News

Bioo Scientific Launches In-Vivo siRNA Delivery Reagent

Bioo Scientific Launches In-Vivo siRNA Delivery Reagent
Product News

Bioo Scientific Launches In-Vivo siRNA Delivery Reagent


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Bioo Scientific Launches In-Vivo siRNA Delivery Reagent"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

RNAi is a potentially powerful but challenging tool for therapeutics and validation studies. One of the primary challenges of achieving optimal in vivo RNAi is developing an effective in vivo siRNA delivery system. The research team at Bioo Scientific developed MaxSuppressor™ In Vivo RNA-LANCEr II delivery reagent, as a solution to this challenge.

Using proprietary technology, the MaxSuppressor In Vivo RNA-LANCEr II delivery reagent simplifies the analysis of in vivo RNAi. According to Lance Ford, VP of Research and Development at Bioo Scientific, “MaxSuppressor In Vivo RNA-LANCEr II is the culmination of 9 years of research in the RNAi field. The delivery offered by MaxSuppressor In Vivo RNA-LANCEr II is critical to the efficiency of in vivo RNAi experiments.”

In addition to efficiently transforming siRNA, the MaxSuppressor In Vivo RNA-LANCEr II delivery reagent has been shown to also efficiently deliver miRNA, long dsRNA and other RNAi agents directly into living animals. It is ideal for use in both basic research and preclinical analysis of drug targets.
Advertisement